Ambulero
Business Services · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1951 NW 7th Ave Ste 600, Miami, Florida,...Website
www.ambulero.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ambulero
Founded in 2019 and based out of Miami, Ambulero is a biotechnology company dedicated to advancing a platform of cell and gene therapies to treat serious vascular diseases.Explore more
Ambulero Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ambulero your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ambulero
Check if Ambulero has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Ambulero recently announced quarterly report
Click to see if Ambulero had a recent Job posting/layoffs
Ambulero, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Ambulero has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Ambulero launches new products
Check out if Ambulero is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Ambulero as Masked Content
Find 2 more new buyers
Compare Similar Companies to Ambulero
Compare insights from companies similar to Ambulero, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ambulero is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ambulero is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ambulero.
Ambulero financials insights
Gather financial insights about Ambulero, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Corporate Investment
$5.5M
Ambulero Tech Stack
A closer look at the technologies used by Ambulero
Ambulero News & Media
Ambulero Finishes Second for Prestigious Cade Prize
MIAMI--(BUSINESS WIRE)--Ambulero, Inc., a Miami, Florida-based biotechnology company, a spinout from the University of Miami Miller School of Medicine (“Ambulero” or the “Company”) developing new gene and cell therapy treatments for severe vascular disease, finished second for the prestigious Cade Prize out of 85 technology and healthcare companies developed from university technology in Florida, Georgia, and Alabama. The Company was voted the top health care company in the competition for itsAmbulero Receives Positive Pre-IND Response from FDA for AMB-301 Treatment of Rare Vascular Disease
MIAMI--(BUSINESS WIRE)--Ambulero, Inc., a Miami, Florida-based spinout from the University of Miami Miller School of Medicine (“Ambulero” or “Company”) developing new gene and cell therapies for severe vascular disease, announces it received a positive response from a Type B Pre-IND meeting with the FDA to develop AMB-301 as a treatment for a rare vascular condition called Buerger’s Disease. AMB-301 is a first-in-class gene therapy vector encoding E-selectin. Over a decade of basic research byAmbulero’s Gene Therapy Candidate AMB-301 Granted US Orphan Drug Designation For Treatment of Severe Vascular Disease
Ambulero Inc Receives Key FDA Recognition For Novel Gene Therapy To Treat Buerger’s Disease (Thromboangiitis Obliterans) Ambulero Inc Receives Key FDA Recognition For Novel Gene Therapy To Treat Buerger’s Disease (Thromboangiitis Obliterans)
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Ambulero
Sign Up For FreeTo access detailed company insights
Founded in 2019 and based out of Miami, Ambulero is a biotechnology company dedicated to advancing a platform of cell and gene therapies to treat serious vascular diseases.... Read More
